Friday, July 13, 2018

Zogenix Inc said on Thursday its drug to treat a rare form of childhood epilepsy reduced convulsive seizures in a second late-stage trial, sending the drug developer's shares up as much as 26 percent.


from Reuters: Health News https://ift.tt/2L7ICZU

Related Posts:

  • LATEST HEALTH NEWSSome hair loss is natural but factors such as stress, malnutrition or nutrient deficiencies, scalp infections, climate change, pollution, fatigue, hormonal imbalance and others can cause hair loss. from Health http://ift.tt/… Read More
  • LATEST HEALTH NEWS(Reuters) - U.S. health regulators have rejected Celgene Corp's application seeking approval of a key multiple sclerosis drug due to insufficient data, the company said on Tuesday, a surprise development that will likely dela… Read More
  • LATEST HEALTH NEWS(Reuters Health) - Mothers of young children may be largely unaware of the biggest burn risks to their little ones and even what age group is most likely to get burned, Australian researchers say. from Reuters: Health Ne… Read More
  • LATEST HEALTH NEWSSummer is upon us and during the said season extra precautions are required to protect oneself against the heat and the sun. from Health http://ift.tt/2oabTpd … Read More
  • LATEST HEALTH NEWS(Reuters Health) - At least one in four teens are receiving sexually explicit texts and emails, and at least one in seven are sending sexts, a new study suggests. from Reuters: Health News http://ift.tt/2Cmtzrn … Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner